Loading…

WuXi Biologics announced plans to build a biologics development, clinical and commercial manufacturing center in Shijiazhuang, Hebei province, with 5,000 L and 48,000 L bioreactor capacity. The initial phase will be operational in 2020.
“We are very pleased to establish the largest biologics center in northern China, which will enable local companies to more effectively develop and manufacture biologics.”wuxibiologics.com
Summarized from public sources; check the original articles before acting on it.